Introduction {#s1}
============

Symplastic growth, characterised by cells that do not alter their relative position to each other, is typical in plant tissue expansion ([@bib26]; [@bib8]). Such development implies supra-cellular (above the level of single cells) regulation, which has an enormous impact on cellular growth control for plant patterning. Despite their importance, molecular mechanisms that restrict cellular and tissue growth are poorly understood in plants.

The phytohormone auxin is a crucial growth regulator and central in differential growth processes. TRANSPORT INHIBITOR RESISTANT1 (TIR1) and its homologs AUXIN F-BOX PROTEINS (AFBs) have been unequivocally demonstrated to be auxin receptors ([@bib13]; [@bib5]). Genomic auxin responses are initiated by auxin binding to TIR1/AFBs, promoting its interaction with proteins of the AUXIN/INDOLE ACETIC ACID (Aux/IAA) family. Auxin-dependent formation of such a co-receptor pair triggers the ubiquitination and subsequent degradation of Aux/IAA proteins. In the absence of auxin, Aux/IAAs form inhibitory heterodimers with AUXIN RESPONSE FACTOR (ARF) family transcription factors. Thus, auxin-dependent Aux/IAA degradation leads to the release of ARF transcription factors and subsequent transcriptional responses (for reviews, see [@bib27]; [@bib31]).

Intriguingly, auxin-signalling events promote and inhibit cellular growth in a cell-type- and auxin concentration-dependent manner. Physiological auxin levels induce growth in light grown aerial tissues, while most root tissues show growth repression in response to the very same auxin concentrations ([@bib31]). The 'acid growth' theory proposes that auxin causes extracellular acidifications and subsequent cell wall remodelling, ultimately driving turgor-dependent cellular expansion ([@bib30]). This theory is based on tissues showing auxin-dependent growth induction. In contrast, relatively little is known of how auxin inhibits cellular growth in other tissues.

The higher plant vacuole is, due to its size, the most prominent plant organelle, and shares its lytic function with its counterparts in yeast and animal lysosomes ([@bib17]). It may likewise be hypothesised that multifunctional plant vacuoles also contribute to cellular size regulation, as the volume of vacuoles correlates with individual cell size in plant cell cultures ([@bib23]). The root epidermis is a suitable model to study such processes ([@bib15]), because it is regularly spaced into shorter tricho- and longer atrichoblast cell files in the late meristematic zone ([@bib2]), which intriguingly, show smaller and larger vacuolar structures, respectively ([@bib2]; [@bib15]). However, the functional importance of this correlation remains to be addressed.

Here we use this cell biological model system to reveal and subsequently characterise auxin-dependent vacuolar morphogenesis and its requirement for limiting cellular growth.

Results {#s2}
=======

Auxin impacts on vacuolar morphology {#s2-1}
------------------------------------

Epidermal cells show smaller and larger vacuolar structures in shorter tricho- and longer atrichoblast cells, respectively ([@bib2]; [@bib15]) ([Figure 1A](#fig1){ref-type="fig"}). We hypothesised that if the vacuolar morphology contributes to cellular size, the growth regulator auxin may impact on its regulation.10.7554/eLife.05868.003Figure 1.Auxin triggered changes in vacuolar morphology correlate with its effect on cell size.(**A**--**C**) Seedlings treated with the solvent DMSO (**A**), auxin (**B**) (NAA 250 nM; 20 hr) or auxin biosynthesis inhibitor kynurenin (**C**) (Kyn) (2 µM; 20 hr). Tonoplast localised VAMP711-YFP (orange) as vacuolar marker and propidium iodide stain (green) for decorating the cell wall were used for confocal imaging of tricho-/atrichoblast (T/A) cells (**A**--**C**). (**D**) Vacuolar morphology (vac. morph. \[µm^2^\]) index of tricho/atrichoblast cells after pharmacological manipulation of auxin levels. (**E**--**G**) Vacuolar morphology of estradiol (10 µM; 20 hr) induced YUCCA6 overexpression (YUC6ox) (**F**) and the respective empty vector control (pER8) (**E**). Tonoplast membrane stain MDY-64 (orange) was used for confocal imaging. (**G**) Vacuolar morphology (vac. morph. \[µm^2^\]) index after genetic manipulation of auxin levels. (**H** and **I**) Quantification of cell length change in tricho-/atrichoblast (T/A) cells following pharmacological (**H**) or genetic manipulation of auxin levels (**I**). For statistical analysis, treated cells were compared to untreated tricho-/atrichoblast. n = 40 cells in 10 individual seedlings for cell length measurement and n = 40 cells in eight individual seedlings for vacuolar morphology index quantification. Error bars represent s.e.m. Student\'s *t*-test p-values: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001. Scale bar: 15 µm (**A**--**C**, **F**, **G**).**DOI:** [http://dx.doi.org/10.7554/eLife.05868.003](10.7554/eLife.05868.003)10.7554/eLife.05868.004Figure 1---figure supplement 1.Quantification of epidermal cell length and vacuolar morphology.(**A**) From the onset of pronounced elongation (atrichoblast cell which is 2.5 times longer than wide), eight atrichoblast cells (depicted in yellow numbers) were counted towards the root tip. At this position, the length of four tricho-/atrichoblast cells (depicted in white numbers) were measured and averaged. Propidium-iodide-stained cell walls (orange). (**B**) The same positional information was used for quantifying the vacuolar morphology. Longest and widest distance was measured in the largest depicted vacuolar structure in four tricho-/atrichoblast cells per root. Vacuolar morphology was depicted by multiplying the distances (**C**) or by dividing the cell length by width (**D**). In this manuscript we mainly used (**C**) as vacuolar morphology index (vac. morph. index). (**E**) Three dimensional representation (orthogonal sectioning) of VAMP711-YFP expressing root epidermis; cross-hair depicts the region of optical sections used for all figures. T refers to trichoblast and A to atrichoblast cell file. Scale bar in (**A**) 50 µm; in (**B**) 10 µm; in (**E**) 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.004](10.7554/eLife.05868.004)10.7554/eLife.05868.005Figure 1---figure supplement 2.Auxin does not affect vacuolar morphology of epidermal root cells in the differentiation zone.DMSO (**A** and **C**) or NAA (**B** and **D**) (250 nM, 20 hr) -treated *pUBQ10::VAMP711-YFP* (orange) expressing seedlings imaged at the onset of root hair bulging (differentiation zone). Propidium-iodide (PI)-stained cell walls (green). (**C** and **D**) Overlay of YFP and PI. Scale bar: 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.005](10.7554/eLife.05868.005)

To specifically investigate the role of auxin in limiting cellular size in roots, we initially assessed how auxin impacts on late meristematic epidermal cells. To allow cellular development under high auxin conditions, we exogenously applied synthetic auxin, 1-naphtylacetic acid (NAA), in nanomolar ranges for 20 hr and screened for subcellular effects that showed differential regulation in neighbouring cells. Remarkably, exogenous application of auxin (NAA \[250 nM\]) or endogenous elevation of YUCCA-dependent auxin biosynthesis led to a dramatic change in vacuolar appearance in root epidermal cells, which consequently displayed smaller luminal vacuolar structures ([Figure 1A,B,E,F](#fig1){ref-type="fig"}).

We established a vacuolar morphology index in epidermal cells based on the biggest luminal structure to further evaluate the apparent auxin effect on vacuolar shape ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). This analysis revealed that high auxin conditions affect vacuolar structures, particularly in atrichoblasts ([Figure 1D,G](#fig1){ref-type="fig"}). Adversely, pharmacological depletion of auxin caused visibly larger vacuolar structures in both cell types, but was more pronounced in trichoblasts (relative to the untreated control) ([Figure 1A,C,D](#fig1){ref-type="fig"}).

This data shows that auxin differentially affects vacuolar shape in neighbouring epidermal cells.

Notably, the differential effect of auxin on vacuoles correlated exactly with a differential effect on cellular size. High auxin levels reduced the cell length of atrichoblast cells ([Figure 1A,B,E,F,H,I](#fig1){ref-type="fig"}), whereas cell lengths of the smaller trichoblasts were not significantly affected ([Figure 1A,B,E,F,H,I](#fig1){ref-type="fig"}). Conversely, pharmacological reduction in auxin biosynthesis mainly increased the cell length in trichoblasts ([Figure 1A,C,H](#fig1){ref-type="fig"}).

Our data shows that the auxin effect on vacuolar morphology correlates with its negative effect on late meristematic epidermal cell size. Auxin treatments manifestly did not reverse vacuolar morphology of fully elongated epidermal root cells in the differentiation zone ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). This finding suggests that auxin mainly shapes vacuoles in growth competent cells.

Next we investigated the auxin effect on vacuoles in the course of time. As the auxin effect on vacuoles was most pronounced in atrichoblasts, we focused our analysis (from here onwards) mainly on this cell-type. Notably, auxin imposed in time steadily increasing effects on vacuolar appearance ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Auxin induced detectable changes in vacuolar morphology already after 15--30 min ([Figure 2A](#fig2){ref-type="fig"}). On the other hand the auxin effect on late meristematic cell size was slightly later starting to be significantly affected around 45 min ([Figure 2B](#fig2){ref-type="fig"}).10.7554/eLife.05868.006Figure 2.Auxin effect on vacuoles precedes cell size regulation.(**A** and **B**) Time course imaging of 250 nM NAA treated seedlings were performed every 15 min. Image acquisition took 10 min per time point. Graphs depict vacuolar morphology index (**A**) and cell length of atrichoblasts (**B**). Untreated seedlings were imaged before and after recording the auxin treated samples and resulting average was defined as T0. Error bars represent s.e.m. For statistical analysis DMSO and NAA treatments were compared. n = 50 cells in 10 individual seedlings for each time point. Student\'s *t*-test p-values: \*p \< 0.05 \*\*p \< 0.01, \*\*\*p \< 0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.006](10.7554/eLife.05868.006)10.7554/eLife.05868.007Figure 2---figure supplement 1.Auxin effect on vacuolar morphology increases in time.Auxin (250 nM NAA) induced changes in vacuolar morphology over time. Error bars represent s.e.m. For statistical analysis DMSO and NAA treatments were compared. n = 50 cells in 10 individual seedlings for each time point. Student´s *t*-test p-values: \*\*\*p \< 0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.007](10.7554/eLife.05868.007)

Based on our time course experiments we conclude that the auxin effect on vacuolar morphology precedes the auxin impact on late meristematic cell size.

TIR1/AFBs-dependent auxin signalling triggers alterations in vacuolar morphology {#s2-2}
--------------------------------------------------------------------------------

We subsequently further characterised the unprecedented role of auxin in vacuolar morphogenesis. The auxin effect on vacuoles was in the time frame of fast transcriptional responses and, subsequently, we tested whether the TRANSPORT INHIBITOR RESISTANT1 (TIR1)/AUXIN F-BOX PROTEINS (AFB) auxin receptors ([@bib14]; [@bib20]) are required for the auxin effect on vacuoles. It has been suggested that auxin analogue 5-F-IAA preferentially triggers genomic auxin responses via TIR1/AFBs ([@bib29]) and it indeed induced small luminal vacuoles ([Figure 3A,B,E](#fig3){ref-type="fig"}). Correspondingly, auxinole, a designated inhibitor of TIR1/AFBs auxin receptors ([@bib12]), blocked the auxin effect on vacuolar morphology ([Figure 3A,C,D,E](#fig3){ref-type="fig"}), and, the genetic reduction of TIR1/AFBs functions in *tir1 afb1 afb3* triple mutants prompted partial resistance to the auxin-induced changes in vacuolar appearance ([Figure 3F--J](#fig3){ref-type="fig"}).10.7554/eLife.05868.008Figure 3.Auxin affects vacuolar morphology in a TIR1/AFBs-dependent manner.(**A**--**D**) Seedlings treated with DMSO (**A**), auxin analogue 5-F-IAA (**B**) (250 nM; 20 hr), TIR1/AFBs antagonist auxinole (**C**) (20 µM; 20 hr) and concomitant with NAA and auxinole (**D**). Tonoplast localised VAMP711-YFP (orange) as vacuolar marker and propidium iodide (green) for decorating the cell wall was used for confocal imaging (**A**--**D**). (**E**) Vacuolar morphology (vac. morph. \[µm^2^\]) index of treatments used in **A**--**D**. For statistical analysis DMSO and treatments were compared. (**F**--**I**) DMSO (**F**) or NAA (**G**) (250 nM; 20 hr) treated control seedlings compared to *tir/afb1/afb3 triple* mutants treated with DMSO (**H**) or NAA (**I**) (250 nM; 20 hr). Tonoplast localised VAMP711-RFP (orange) as vacuolar marker was used for confocal imaging in **F**--**I**. (**J**) Vacuolar morphology (vac. morph. \[µm^2^\]) index of treatments shown in **F**--**I**. For statistical analysis either DMSO or NAA treatments were compared between control and indicated mutant. n= 40 cells in eight individual seedlings. Error bars represent s.e.m. Student\'s *t*-test P-values: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.008](10.7554/eLife.05868.008)

This set of data indicates that TIR1/AFBs-dependent auxin signalling is required for the auxin effect on vacuolar morphogenesis.

TIR1/AFBs-dependent auxin perception posttranslationally stabilises vacuolar SNAREs {#s2-3}
-----------------------------------------------------------------------------------

In the following we got interested in **SNA**P (Soluble NSF Attachment Protein) **Re**ceptor (SNARE) complexes at the vacuole. Proximity of adjacent membrane allows the interaction of v (vesicle)- and t (target)-SNAREs to form a complex, allowing the fusion of vesicles to specific target membranes. SNAREs are essential for eukaryotic vesicle trafficking and according to structural features SNAREs are divided in R (arginine)- and Q (glutamine)-SNAREs ([@bib16]). In yeast, the SNARE complex is furthermore central in homotypic vacuolar membrane remodelling and proteomic approaches have identified conserved SNARE complexes at the plant tonoplast ([@bib3]). Ergo, we tested whether auxin affects vacuolar SNAREs in *Arabidopsis*. Remarkably, increased auxin biosynthesis or exogenous application of auxin increased the fluorescence intensity of tonoplast localised SNAREs, such as VAMP711-YFP, SYP21-YFP and SYP22-GFP ([Figure 4A--L,N,O](#fig4){ref-type="fig"}). Auxin severely impacts on vacuolar appearance and, hence, it could be that membrane crowding induces higher fluorescence. To address this question we performed co-localisation of VAMP711-RFP/YFP and membrane dyes, such as FM4-64 and MDY-64. Notably, VAMP711-RFP/YFP, but not the membrane dyes showed auxin-induced signal intensities, suggesting that the auxin effect on vacuolar SNAREs does not rely on membrane crowding ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).10.7554/eLife.05868.009Figure 4.Auxin posttranslationally stabilises tonoplast localised SNAREs.(**A**--**L**) Tonoplast localised SNAREs and marker protein NET4A under high auxin conditions. *pUBQ10::VAMP711-YFP* (**A** and **B**), *35S::SYP21-YFP* (**C** and **D**), *SYP22::SYP22-GFP* (in *syp22*) (**E** and **F**) and *NET4A::NET4A-GFP* (**G** and **H**) expressing seedlings treated with DMSO (**A**, **C**, **E**, **G**) or NAA (**B**, **D**, **F**, **H**) (500 nM; 20 hr). (**I** and **J**) Estradiol does not affect VAMP711-YFP abundance. *pUBQ10::VAMP711-YFP* expressing seedlings treated with DMSO (**I**) or estradiol (**J**) (10 µM estradiol; 20 hr). YUCCA6 expression under control of an estradiol inducible promoter in *pUBQ10::VAMP711-YFP* expressing seedlings after DMSO (**K**) or estradiol (**L**) (10 µM; 20 hr) treatment. Propidium iodide (green) for decorating the cell wall was used for confocal imaging of atrichoblast cells. (**M**) Western-blot (anti-GFP) representing VAMP711-YFP, SYP21-YFP, SYP22-GFP and NET4A-GFP protein abundance after NAA (500 nM; 20 hr) and control treatment as well as corresponding alpha-tubulin abundance for normalization. (**N**) Mean grey value of vacuolar localised SNAREs and marker protein NET4A after auxin treatments (500 nM; 20 hr) compared to DMSO treatments. (**O**) Mean grey value of VAMP711-YFP after YUCCA6 induction (10 µM; 20 hr). (**P**) Western-blot quantification (mean grey values). n = 3 biological replicates each consisting of a pool of 40--50 roots. Error bars represent s.e.m. For statistical analysis DMSO and NAA treatments were compared. For confocal analysis (**N**-**O**): n = 32 cells in eight individual seedlings. Student\'s *t*-test p-values: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.009](10.7554/eLife.05868.009)10.7554/eLife.05868.010Figure 4---figure supplement 1.Increase in SNARE intensity is independent of membrane crowding.(**A**--**J**) Simultaneous imaging of VAMP711-RFP/YFP and tonoplast staining dyes under untreated and high auxin conditions. *pUBQ10::VAMP711-RFP* (**A** and **B**) and *pUBQ10::VAMP711-YFP* (**F** and **G**) expressing seedlings were counterstained either with MDY-64 (**C** and **D**) or FM4-64 (**H** and **I**) and treated with DMSO (**A** and **C**) or NAA (**B** and **D**) (500 nM; 20 hr). (**E**) Quantification of mean grey value of VAMP711-RFP and MDY-64 after NAA treatments (500 nM) compared to DMSO control. (**J**) Quantification of mean grey value of VAMP711-YFP and FM4-64 after NAA treatments (500 nM) compared to DMSO control. Error bars represent s.e.m. For statistical analysis DMSO and NAA treatments were compared. n = 40 cells in 10 individual seedlings. Student\'s *t*-test p-values: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.010](10.7554/eLife.05868.010)10.7554/eLife.05868.011Figure 4---figure supplement 2.Auxin affects cellular abundance of vacuolar SNAREs.(**A**--**H**) Maximum projection of tonoplast localised SNAREs and marker protein NET4A under high auxin conditions. *pUBQ10::VAMP711-YFP* expressing seedlings treated with DMSO (**A**) or NAA (**B**) (500 nM; 20 hr). *35S::SYP21-YFP* expressing seedlings treated with DMSO (**C**) or NAA (**D**) (500 nM; 20 hr). *SYP22::SYP22-GFP* (in *syp22*) expressing seedlings treated with DMSO (**E**) or NAA (**F**) (500 nM; 20 hr). *NET4A::NET4A-GFP* expressing seedlings treated with DMSO (**G**) or NAA (**H**) (500 nM; 20 hr). 17--20 steps of 1 µm size were used for image acquisition. (**I**) Mean grey value of vacuolar SNAREs and tonoplast marker NET4A in DMSO control and auxin treatments (500 nM; 20 hr). Error bars represent s.e.m. For statistical analysis DMSO and NAA treatments were compared. Student\'s *t*-test p-values: \*\*p \< 0.01, \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.011](10.7554/eLife.05868.011)10.7554/eLife.05868.012Figure 4---figure supplement 3.Induction of a single SNARE component is not sufficient to affect vacuolar morphology.(**A**--**D**) Estradiol induction of VAMP711. *pMDC7::citrus-flag* (control) after DMSO (**A**) or estradiol (**B**) (2 µM) treatment. *VAMP711* expression under control of an estradiol inducible promoter after DMSO (**C**) or estradiol (**D**) (2 µM) incubation. Vacuoles were decorated with FM4-64 (orange). (**E**) Semi-quantitative RT-PCR of *VAMP711* in *pMDC7::citrus-flag* and *pMDC7::VAMP711* expressing plants with (+) and without (−) estradiol induction (2 µM; 20 hr). *UBQ-5* expression was used for normalisation. Depicted values represent quantification of mean grey values of corresponding bands. (**F**) Vacuolar morphology (vac. morph. \[µm^2^\]) index of estradiol induced *pMDC7::citrus-flag* and *pMDC7::VAMP711* expressing seedlings compared to the uninduced control. Scale bar, 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.012](10.7554/eLife.05868.012)

Exogenous application of auxin does not detectably impact on cytosolic pH ([@bib11]). However, to fully preclude that pH sensitivity may affect fluorescence of VAMP711-YFP (YFP faces the cytosol), we also utilized more pH resistant RFP fusions. The auxin effect on VAMP711 was detectable in both pH sensitive YFP and pH resistant RFP fusions ([Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}; [Figure 5A,B](#fig5){ref-type="fig"}), suggesting that the auxin effect on SNAREs does not indirectly rely on cytosolic pH.10.7554/eLife.05868.013Figure 5.TIR1/AFBs-dependent auxin perception is required for posttranslational VAMP711 stabilisation.(**A**--**D**) Pharmacological inhibition of TIR1/AFBs dependent signalling. *pUBQ10::VAMP711-YFP* expressing seedlings treated with DMSO (**A**), NAA (**B**) (500 nM; 20 hr), auxinole (**C**) (20 µM; 20 hr) or auxinole/NAA co-treatment (**D**). (**E**) Mean grey value of VAMP711-YFP abundance after NAA or NAA/auxinole co-treatments. (**F**--**I**) Genetic inhibition of TIR1/AFBs signalling. VAMP711-RFP expressing control seedlings (for **H** and **I**) treated with DMSO (**F**) and NAA (**G**) (500 nM; 20 hr). VAMP711-RFP abundance in *tir1-1/afb1-3/afb3-4* mutant background after DMSO (**H**) or NAA (**I**) (500 nM; 20 hr) treatment. (**J**) Mean grey value of treatments in **F**--**I**. VAMP711-YFP/RFP (orange) as a vacuolar marker and propidium iodide (green) for decorating the cell wall were used for confocal imaging of atrichoblast cells. n = 32 cells in eight individual seedlings. Error bars represent s.e.m. For statistical analysis either DMSO or NAA treatments were compared between control and indicated mutant/treated seedlings. Student\'s *t*-test p-values: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.013](10.7554/eLife.05868.013)

To assess whether auxin treatments affect the overall cellular abundance of vacuolar SNAREs, we performed defined z-stack imaging. Subsequent maximum projections and intensity measurements confirmed that auxin increases cellular SNARE abundance at the tonoplast ([Figure 4---figure supplement 2A--I](#fig4s2){ref-type="fig"}). To further emphasize on this finding, we also performed western blots on excised root tips, similarly confirming our conclusion that auxin increases vacuolar SNARE abundance ([Figure 4M,P](#fig4){ref-type="fig"}).

Notably, tonoplast marker NET4A-GFP ([@bib4]) did not show auxin-induced stabilization ([Figure 4G,H](#fig4){ref-type="fig"}; [Figure 4---figure supplement 2G,H](#fig4s2){ref-type="fig"}), suggesting certain specificity for the auxin effect on vacuolar SNAREs. This set of data indicates that auxin affects vacuolar SNARE function.

Induction of a single SNARE component, such as VAMP711, did not affect vacuolar morphogenesis ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}), possibly indicating the joint requirement of several complex components. Furthermore, auxin modulated SNARE proteins also when expressed under constitutive promoters ([Figure 4A--D,I--N](#fig4){ref-type="fig"}). This data implies that auxin affects the vacuolar SNAREs posttranslationally.

Next we tested whether TIR1/AFBs-dependent auxin perception mechanisms are required for the auxin effect on vacuolar SNAREs. Concomitant treatments with auxin and the TIR1/AFBs antagonist auxinole comprehensively interfered with auxin-induced stabilisation of VAMP711-YFP ([Figure 5A--E](#fig5){ref-type="fig"}). Concurrently, the auxin effect on vacuolar SNAREs was also significantly reduced in the *tir1 afb1 afb3* triple mutant ([Figure 5F--J](#fig5){ref-type="fig"}). Hence, pharmacologic and genetic interference with TIR1/AFBs did not only inhibit the auxin effect on vacuoles, but also abolished the posttranslational effect of auxin on VAMP711.

We conclude that the TIR1/AFBs-dependent auxin signalling triggers higher SNARE abundance at the tonoplast.

Vacuolar SNARE VTI11 function is required for the auxin-dependent modulation of vacuolar morphology {#s2-4}
---------------------------------------------------------------------------------------------------

It has been suggested that several vacuolar SNARE components act redundantly ([@bib36]; [@bib34]) and also in our conditions most analysed *SNARE* single mutants displayed vacuolar morphology reminiscent to wild type ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). In contrast, *vti11* mutant alleles display roundish vacuoles in untreated conditions ([@bib36]; [@bib37]) ([Figure 6A,C](#fig6){ref-type="fig"}). Despite these apparent defects, vacuoles remained differentially controlled in *vti11* mutant tricho- and atrichoblast cells ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}), indicating that the cell type-dependent regulation of vacuolar morphology is at least partially operational in *vti11* mutants.10.7554/eLife.05868.014Figure 6.SNARE-dependent vacuolar morphogenesis is required for auxin regulated cell size determination.(**A**--**F**) Vacuolar morphology and cell size determination in the *vti11* mutant. Control treatment of *Col-0* with DMSO (**A**) or NAA (**B**) (250 nM; 20 hr). *vti11* mutants were treated with DMSO (**C**) or NAA (**D**) (250 nM; 20 hr). MDY-64 (orange) and propidium iodide (green) were used for confocal imaging of atrichoblast cells (**A**--**D**). (**E**) Vacuolar morphology (vac. morph. \[µm^2^\]) index of prior treatments in *Col-0* and *vti11* mutant. (**F**) Cell length change of *Col-0* and *vti11* atrichoblast cells after NAA (250 nM; 20 hr) treatment compared to DMSO control. n = 40 cells in eight individual seedlings for vacuolar morphology index quantification and n = 40 cells in 10 individual seedlings for cell size measurements. Error bars represent s.e.m. For statistical analysis either DMSO or NAA treatments were compared between control and indicated mutant/treated seedlings. Student\'s *t*-test p-values: \*\*p \< 0.01, \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.014](10.7554/eLife.05868.014)10.7554/eLife.05868.015Figure 6---figure supplement 1.Auxin affects vacuolar morphology in several vacuolar *snare* single mutants.(**A**--**H**) Overview of the vacuolar morphology in single *snare* mutants after auxin treatment. Control treatment of *Col-0* with DMSO (**A**) or NAA (**B**) (250 nM; 20 hr). *syp21* treated with DMSO (**C**) or NAA (**D**) (250 nM; 20 hr). *syp22* treated with DMSO (**E**) or NAA (**F**) (250 nM; 20 hr) and *vamp711* treated with DMSO (**G**) or NAA (**H**) (250 nM; 20 hr). Vacuoles were decorated with MDY-64 (orange) and propidium iodide (PI) was used for counterstaining the cell walls (green). (**I**) Vacuolar morphology (vac. morph. \[µm^2^\]) index of DMSO (control) and NAA (250 nM; 20 hr) treated *Col-0* and mutant atrichoblast cells. (**J**) Semi-quantitative RT-PCR of *VAMP711* in *Col-0* and *vamp711* mutant line showing knock down of *VAMP711* transcripts. *UBQ-5* expression was used for normalisation. Depicted values represent quantification of mean grey values of corresponding bands. n = 40 atrichoblast cells in eight individual roots for vacuolar morphology index determination. Error bars represent s.e.m. Student\'s *t*-test p-value: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.015](10.7554/eLife.05868.015)10.7554/eLife.05868.016Figure 6---figure supplement 2.The vacuolar morphology in the *vti11* mutant remained differentially controlled in tricho-/atrichoblast root epidermal cells.(**A** and **B**) Root epidermal tricho- and atrichoblast cells of *Col-0* (**A**) or *vti11* mutant (**B**) were decorated with MDY-64. (**C**) Vacuolar morphology (vac. morph. \[µm^2^\]) index of *Col-0* and *vti11* tricho- and atrichoblast cells. (**D**) Mean cell length of *Col-0* and *vti11* tricho- and atrichoblast cells. For statistical analysis *vti11* tricho- and atrichoblast cells were compared to wild-type tricho- and atrichoblast cells. T refers to trichoblast and A to atrichoblast cell files. n = 40 quantified cells in eight seedlings for vacuolar morphology index measurements and n = 40 quantified cells in 10 seedlings for cell length quantification. Error bars represent s.e.m. Student\'s *t*-test p-value: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.016](10.7554/eLife.05868.016)10.7554/eLife.05868.017Figure 6---figure supplement 3.The pVTI11:VTI11-GFP complements auxin phenotypes in *vti11* mutant.Control treatment of *Col-0* (**A** and **B**) and *vti11* (**C** and **D**) with DMSO (**A** and **C**) or NAA (**B** and **D**) (250 nM; 20 hr). (**E**--**J**) *VTI11::GFP-VTI11* expressing *vti11* seedlings under control and high auxin conditions. (**E**) DMSO control treatment of VTI11-GFP expressing *vti11* cells. (**H**) NAA treatment (250 nM; 20 hr) of VTI11-GFP expressing *vti11* cells. Samples were counterstained with FM4-64 (**F** and **I**) and respective overlay (**G** and **J**) is shown. (**K**) Vacuolar morphology index of DMSO control and NAA (250 nM; 20 hr) treated *Col-0* and mutant atrichoblast cells. (**L** and **M**) Complementation of *vti11*. (**L**) Root growth of *Col-0*, *vti11* and *VTI11::GFP-VTI11* in *vti11* after control and NAA (125 nM) treatment. (**M**) Quantification of root growth inhibition in *Col-0*, *vti11* and *VTI11::GFP-VTI11* in *vti11* after NAA (125 nM) treatment. n = 40 atrichoblast cells in eight individual roots for vacuolar morphology index determination and n = 20--25 roots for root growth inhibition. For statistical analysis *Col-0* were compared with mutant seedlings. Error bars represent s.e.m. Student\'s *t*-test p-value: \*\*\*p \< 0.001. Scale bar, in **A**--**J**: 15 µm; in **L**: 1 cm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.017](10.7554/eLife.05868.017)

We, hence, have chosen *vti11* mutants for further investigation and tested if VTI11 function is required for the auxin effect on vacuoles. Auxin treatments were less effective to modulate vacuolar morphology in *vti11* mutants ([Figure 6A--E](#fig6){ref-type="fig"}). Notably, pVTI11:VTI11-GFP expression in *vti11* mutant cells induced reversion to auxin sensitive vacuolar morphology ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). This data indicates that auxin does not only affect SNARE abundance, but requires functional Q-SNARE VTI11 to modulate vacuolar shapes.

Vacuoles partially escaped auxin regulation in *vti11* mutants, allowing us to assess the requirement of VTI11 function for auxin-dependent limitation of meristematic cell size. Interestingly, *vti11* mutants were not only partially resistant to the auxin effect on vacuoles, but in addition, less sensitive to the negative impact of auxin on late meristematic cell size ([Figure 6A--D,F](#fig6){ref-type="fig"}). This data suggests that VTI11 function is required for the auxin effect on vacuolar shape and late meristematic cell size.

Interference with phosphatidylinositol homeostasis affects vacuolar SNAREs and impedes auxin-dependent cell size control {#s2-5}
------------------------------------------------------------------------------------------------------------------------

Several phosphatidylinositol (PI) -dependent processes have been previously shown to play a role in vacuolar biogenesis in yeast ([@bib19]) and also impact on vacuolar morphology in plants ([@bib22]; [@bib37]). PI3/4 kinase inhibitor Wortmannin (WM) affects vacuolar morphology and has been recently proffered as affecting processes upstream of vacuolar SNAREs in plants ([@bib9]; [@bib37]). WM treatments led to larger luminal vacuoles and abolished the auxin effect on vacuoles ([Figure 7A--E](#fig7){ref-type="fig"}). It may be noted that the negative effect of auxin on limiting late meristematic cell size was also abolished after low doses of WM \[2 µM\] ([Figure 7F](#fig7){ref-type="fig"}). This data suggests that WM sensitive processes may contribute to auxin-dependent vacuolar morphogenesis and cell size regulation.10.7554/eLife.05868.018Figure 7.PI4-kinase function is required for auxin dependent vacuolar morphology, cell size determination and control of posttranslational VAMP711 abundance.(**A**--**G**) Effect of wortmannin (WM) on auxin regulated vacuolar morphology, cell growth inhibition and VAMP711 abundance. Control treatment of VAMP711-YFP atrichoblasts with DMSO (**A**) or NAA (**B**) (250 nM; 20 hr). VAMP711-YFP expressing seedlings after WM (**C**) (10 µM; 20 hr) or NAA/WM co-treatment (**D**). Quantification of vacuolar morphology (vac. morph. \[µm^2^\]) index (**E**) and cell length change (**F**). (**G**) Relative mean grey value of VAMP711-YFP abundance after NAA (500 nM; 20 hr) and/or WM (10 µM; 20 hr) treatment. Corresponding images are shown in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. (**H**--**M**) Effect on auxin regulated vacuolar morphology, cell growth inhibition and VAMP711 abundance in *pi4kß1/2* plants. Control treatment of VAMP711-YFP atrichoblasts with DMSO (**H**) or NAA (**I**) (100 nM; 20 hr) for comparability. VAMP711-YFP expression in *pi4kß1/2* mutant background after DMSO (**J**) or NAA (**K**) (100 nM; 20 hr) treatment. Quantification of vacuolar morphology (vac. morph. \[µm^2^\]) index (**L**) and cell length change (**M**). (**N**) Absolute mean grey value of VAMP711-YFP abundance after NAA (500 nM; 20 hr) treatment in the *pi4kß1/2* mutant background. Corresponding images are shown in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. VAMP711-YFP (orange) as a vacuolar marker and propidium iodide (green) for decorating the cell wall were used for confocal imaging of atrichoblast cells. n = 32 cells in eight individual seedlings for cell length measurements and n = 40 cells in eight individual seedlings for vacuolar morphology index quantification. Error bars represent s.e.m. For statistical analysis either DMSO or NAA treatments were compared between control and indicated mutant/treated seedlings. Student\'s *t*-test p-values: \*\*p \< 0.01, \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.018](10.7554/eLife.05868.018)10.7554/eLife.05868.019Figure 7---figure supplement 1.PI4 kinases posttranslationally control VAMP711 abundance.(**A**--**D**) Wortmannin inhibits the auxin effect on VAMP711 stabilisation. VAMP711-YFP signal after DMSO (**A**) or NAA (**B**) (500 nM; 20 hr) (control for **C** and **D**) treatment. VAMP711-YFP seedlings treated with wortmannin (WM) (**C**) (10 µM; 20 hr) or WM and NAA (**D**) (500 nM; 20 hr). (**E**--**H**) Reduced VAMP711 abundance in *pi4kß1/2* mutants. Control treatment of VAMP711-YFP with DMSO (**E**) or NAA (**F**) (500 nM; 20 hr). *pi4kß1/2* seedlings expressing *pUBQ10::VAMP711-YFP* treated with DMSO (**G**) or NAA (**H**) (500 nM; 20 hr). VAMP711-YFP (orange) as a vacuolar marker and propidium iodide (green) for decorating the cell wall were used for confocal imaging of atrichoblast cells. n = 32 cells in eight individual seedlings. Error bars represent s.e.m. For statistical analysis either DMSO or NAA treatments were compared between control and indicated mutant/treated seedlings. Student\'s *t*-test p-values: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.019](10.7554/eLife.05868.019)10.7554/eLife.05868.020Figure 7---figure supplement 2.Tricho-/atrichoblast cell length in wortmannin treated samples.(**A** and **B**) Root epidermal tricho-/atrichoblast cells of VAMP711-YFP expressing seedlings after DMSO (**A**) or WM (**B**) (10 µM; 20 hr) treatment. (**C**) Mean epidermal cell length in the root meristem of DMSO or WM (2 µM; 20 hr) treated seedlings. n = 40 quantified cells in eight seedlings. Error bars represent s.e.m. Student\'s *t*-test p-value: \*\*\*p \< 0.001. Scale bar: 15 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.020](10.7554/eLife.05868.020)

To substantiate this pharmacological data, we subsequently screened the relevant literature for WM sensitive molecular components, which may affect root epidermal processes. PI4Kß1 and PI4Kß2 are expressed in root epidermal cells and redundantly control mature root hair morphology ([@bib25]). We therefore tested the auxin effect on vacuolar morphology in *pi4kß1/2* double mutants. Compared to wild-type seedlings, *pi4kß1/2* double mutants showed partially auxin resistant vacuolar appearance ([Figure 7H--L](#fig7){ref-type="fig"}). Moreover, the genetic interference with PI4Kß-function was reminiscent of WM treatments and also abolished the auxin effect on reducing late meristematic cell size ([Figure 7M](#fig7){ref-type="fig"}).

Based on our pharmacological and genetic data, we conclude that PI-dependent processes affect auxin-dependent vacuolar morphology.

We subsequently addressed whether the obstruction of PI homeostasis may impair auxin-dependent posttranslational regulation of SNARE proteins. Concomitant treatments with PI3/4-kinase inhibitor WM and auxin completely diminished the auxin effect on vacuolar SNAREs even at relatively high auxin levels (NAA \[500 nM\]) ([Figure 7G](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1A--D](#fig7s1){ref-type="fig"}). This data suggests that WM sensitive processes interfere with both the auxin effect on vacuolar morphology and the auxin-dependent regulation of vacuolar SNARE abundance. Analogously, the *pi4kß1/2* double mutants showed reduced VAMP711-YFP abundance in untreated and auxin treated conditions ([Figure 7N](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1E--H](#fig7s1){ref-type="fig"}). We accordingly conclude that auxin requires PI4K activity to modulate vacuolar SNAREs.

In contrast to WM, SNARE stability was still increased in response to high auxin (NAA \[500 nM\]) in *pi4kß1/2* double mutants ([Figure 7N](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1E--H](#fig7s1){ref-type="fig"}). Notably, *pi4kß1/2* double mutants showed auxin sensitive vacuolar morphogenesis at these higher auxin levels ([Figure 7---figure supplement 1G,H](#fig7s1){ref-type="fig"}). Based on this data, we assume that PI4 kinase activity and possibly other, WM sensitive, PI-dependent processes affect auxin-dependent posttranslational regulation of vacuolar SNARE proteins. We conclude that the PI-dependent interference with the auxin effect on vacuolar SNAREs completely coincides with a reduced impact of auxin on vacuolar morphology and meristematic cell size.

Auxin effect on vacuolar morphogenesis interrelates with auxin-dependent cellular growth inhibition {#s2-6}
---------------------------------------------------------------------------------------------------

Here we show that auxin limits cellular vacuolisation, correlating with its negative impacts on meristematic cell size. Prolonged auxin treatments shift the cell length ratio of tricho- and atrichoblasts. Assuming that there is no cellular sliding, the auxin effect on meristematic cell size might not only depend on cellular expansion, but also on altered division rates. To exclude cell division and to assess whether the auxin effect on vacuolar morphology could limit cellular growth, we subsequently concentrated solely on cellular expansion of epidermal cells in the elongation zone and recorded their maximum expansion under high auxin conditions. As expected, auxin repressed cellular elongation in wild-type epidermal cells ([Figure 8A,B](#fig8){ref-type="fig"}). In contrast, pharmacological inhibition of PI3 and PI4 kinases led to reduced sensitivity to auxin-dependent inhibition of epidermal growth ([Figure 8C,D,I](#fig8){ref-type="fig"}). *pi4kß1/2* double mutants were similarly resistant to the auxin-dependent inhibition of cellular expansion ([Figure 8E,F,J](#fig8){ref-type="fig"}).10.7554/eLife.05868.021Figure 8.Auxin dependent vacuolar morphogenesis links auxin dependent growth inhibition.(**A**--**H**) Fully elongated root cells in the differentiation zone of *Col-0* after DMSO (**A**), NAA (**B**) (250 nM), WM (**C**) (2 µM), WM+NAA (**D**) and *pi4kß1/2* after DMSO (**E**) or NAA (**F**) (250 nM), as well as *vti11* after DMSO (**G**) or NAA (**H**) (250 nM) treatments. (**I**) Cell length change of *Col-0* trichoblast cells after NAA (250 nM; 20 hr) and/or WM (2 µM; 20 hr) treatment. (**J**) Cell length change of *Col-0* and *pi4kß1/2* trichoblast cells after NAA (250 nM; 20 hr) treatment. (**K**) Cell length change of *Col-0* and *vti11* trichoblast cells after NAA (250 nM; 20 hr) treatment. (**L**) NAA mediated root growth inhibition of *Col-0*, *pi4kß1/2* and *vti11* after NAA (125 nM) and/or WM (2 µM) treatment. (**M**) Quantification of root growth inhibition in *Col-0* after NAA (125 nM) and/or WM (2 µM) treatment (germinated; 12 DAG). (**N**) Quantification of root growth inhibition *Col-0* and *pi4kß1/2* after NAA (125 nM) treatment (germinated; 8 DAG). (**O**) Quantification of root growth inhibition in *Col-0* and *vti11* after NAA (125 nM) treatment (germinated; 8 DAG). Propidium iodide (red) for decorating the cell wall was used for confocal imaging of epidermal cells. For cell length change n = 30 seedlings out of three independent experiments with approximately 90--120 quantified cells in total; and n = 20--25 roots for root growth inhibition. Error bars represent s.e.m. For statistical analysis either NAA or WM treatments were compared between control and/or indicated mutant/treated seedlings. Student\'s *t*-test p-values: \*p \< 0.05, \*\*\*p \< 0.001. Scale bar: 50 µm (**A**--**H**); 1 cm (**L**).**DOI:** [http://dx.doi.org/10.7554/eLife.05868.021](10.7554/eLife.05868.021)10.7554/eLife.05868.022Figure 8---figure supplement 1.Root growth of *pi4kß1/2* mutants reacts to auxin in a dose dependent manner.(**A**--**D**) Root growth and length quantification of *Col-0* and *pi4kß1/2* seedlings under high auxin conditions. (**A**) Root growth of *Col-0* seedling according to different NAA concentrations (300 nM and 600 nM NAA). (**B**) Root growth of *pi4kß1/2* seedling according to different NAA concentrations (300 nM and 600 nM NAA). (**C**) Mean root growth inhibition of *Col-0* and pi4kß1/2 in responce to different auxin concentrations (300 nM and 600 nM NAA). (**D**) Relative root growth inhibition of *Col-0* and pi4kß1/2 in response to different auxin concentrations (300 nM and 600 nM NAA). n = 20--25 roots per treatment. Error bars represent s.e.m. Student\'s *t*-test p-value: \*\*\*p \< 0.001. Scale bar: 1 cm.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.022](10.7554/eLife.05868.022)

Subsequently, we tested root organ growth in response to auxin. Exogenous application of auxin strongly reduced the root length of wild-type seedlings, but was less effective following pharmacological (WM treated wild-type) and genetic interference (*pi4kß1/2* double) with PI kinases ([Figure 8L--N](#fig8){ref-type="fig"}). Notably and comparable with our cellular analysis, increased auxin concentrations led to root growth inhibition also in *pi4kß1/2* double mutants ([Figure 8---figure supplement 1A--D](#fig8s1){ref-type="fig"}). In conclusion, this data suggests that PI-dependent processes contribute to auxin-dependent inhibition of cellular and root organ growth.

Thereafter we likewise addressed auxin dependent inhibition of cellular expansion in VTI11 deficient roots. In agreement with our data on meristematic cell size control, cellular elongation was also less sensitive to auxin in *vit11* mutants ([Figure 8G,H,K](#fig8){ref-type="fig"}). The negative effect of auxin on root organ growth was also reduced in *vti11* mutants ([Figure 8L,O](#fig8){ref-type="fig"}), but was complemented by VTI11-GFP expression ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). Therefore, we conclude that auxin requires VTI11 function to inhibit cellular expansion and moreover root organ growth.

We have demonstrated that auxin interferes with SNARE abundance at the tonoplast, correlating with its effect on vacuolar morphology. What is striking is that auxin-dependent modulation of vacuolar shape precisely coincides with auxin dependent growth inhibition. Pharmacological and genetic interference with the auxin-dependent regulation of SNARE abundance corresponds with auxin resistant vacuolar morphology. Moreover, abrogation of the cellular auxin effect on vacuolar morphology interrelates with lower sensitivity to auxin-dependent inhibition of cellular growth.

We propose, based on these independent lines of evidence, that auxin signalling utilises SNARE-dependent vacuolar morphogenesis to restrict cellular expansion. Such regulation could have widespread developmental consequences, such as determining root organ growth rates.

Discussion {#s3}
==========

It has been noted that the morphology of plant vacuoles correlate with cell size ([@bib23]; [@bib2]; [@bib15]) and, hence, it was tempting to postulate that vacuoles may even drive cellular growth ([@bib17]). Surprisingly, little is actually known about mechanisms controlling vacuolar morphology and whether the vacuoles are indeed involved in growth regulation. Plant vacuoles, inter alia, are claimed to be important cellular osmoregulators, and accordingly, have been hypothesised as contributing to turgor-dependent cellular growth induction ([@bib17]). This may explain the correlation between vacuolarisation with cellular size. Though appealing, also this hypothesis awaits experimental validation. Hence, the potential role of auxin in turgor regulation should also be carefully assessed. Just such a role has been insinuated in recent papers related to lateral root emergence. Auxin responses have been reported to reduce cellular pressure in cell files facing lateral root primordia ([@bib24]) and vacuolar morphology alterations have been recently described in endodermal tissues during lateral root emergence ([@bib24]; [@bib35]). However, these proposed auxin responses are not related to cellular growth regulation and it remains to be seen whether the auxin impact on vacuolar morphology described here is related to interference with turgor pressure.

Here we show that auxin controls the overall vacuolar morphology. Several pieces of independent evidence suggest that the modulation of the vacuolar SNAREs allows the phytohormone auxin to limit cellular growth. Future studies will further assess the precise molecular role of vacuolar SNAREs in shaping the plant vacuole. Auxin impacts on vacuolar SNAREs in a posttranslational manner and it is tempting to speculate that auxin could impose a conformational change on the SNARE complex, possibly affecting its stability and activity. Accordingly, the auxin effect on vacuolar SNAREs could impact on homotypic vacuolar fusion events, leading to smaller luminal structures. Alternatively, also a structural role of SNAREs has been envisioned ([@bib7]), which could be yet another mechanism to impact on vacuolar organisation. Notably, a recent study suggested that most vacuolar structures are interconnected within an untreated cell ([@bib38]). Hence, it needs to be seen how precisely auxin impacts on vacuolar morphology and whether these structures are still interconnected in high auxin conditions.

We assume that auxin utilises the plant vacuole as a cellular effector to restrict cellular expansion. Hence, we conclude that previous correlative observations on cell size and vacuolar morphology ([@bib23]; [@bib2]; [@bib15]) may not reflect that vacuoles drive growth, but rather rely on a vacuole-dependent cellular mechanism that limits growth.

Our data extends the current view of auxin biology, suggesting that auxin coordinates extracellular and intracellular components, such as cell wall acidification ([@bib30]; [@bib33]) and vacuolar morphogenesis, for driving and restricting cellular growth. In this light, the luminal increase of plant vacuoles alone may not be sufficient to induce larger cell sizes ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}; [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}) due to cell wall limitations. In contrast, limiting cellular vacuolarisation appears sufficient to restrict cellular growth. Such a dual growth mechanism would allow plants to dynamically de- and accelerate cellular expansion, integrating multiple distinct, possibly conflictive internal and external triggers.

Materials and methods {#s4}
=====================

Plant material, growth conditions and DNA constructs {#s4-1}
----------------------------------------------------

We used *Arabidopsis thaliana* of ecotype *Columbia 0* (*Col-0*). *vamp711* (N673991), obtained from the Nottingham Arabidopsis stock centre and the decrease of *VAMP711* transcript was shown by RT-PCR. Other plant lines were described previously, *pUBQ10::VAMP711-YFP/RFP* (Wave 9Y/R) ([@bib10]), *pER8* and *pER8::YUC6* ([@bib18]), *tir triple: tir1-1/afb1-3/afb3-4* ([@bib6]), *pi4kß1/2* ([@bib25]), *35S::SYP21-YFP* ([@bib28]), *SYP22::SYP22-GFP* in *syp22* background ([@bib34]), *syp21* (*pep12*) ([@bib34]), *syp22* (*vam3-1*) ([@bib34]), *vti11* (zigzag) ([@bib36]), *VTI11::GFP-VTI11* in *vti11* ([@bib21]), *NET4A::NET4A-GFP* ([@bib4]). The *pi4kß1/2* and *pER8::YUC6* were crossed into Wave 9Y, respectively. *tir triple* plants expressing Wave 9R were obtained by floral dipping in *Agrobacterium tumefaciens* liquid cultured cells harbouring the Wave 9R vector and were subsequently selected on Basta (Bayer, Germany) supplemented MS plates. Seeds were stratified at 4°C for 2 days in the dark and grown on vertically orientated ½ Murashige and Skoog (MS) medium plates under a long-day regime (16 hr light/8 hr dark) at 20--22°C. Gateway cloning was used to construct pMDC7_B(pUBQ)::VAMP711 (Destination vector from [@bib1]). The *VAMP711* fragment was amplified with the high-fidelity polymerase 'I proof' (BioRad, CA, USA) from the Wave line vector harbouring VAMP711 (Wave 9Y). The primers were designed using life technologies OligoPerfect ([www.lifetechnologies.com/oligoperfect](http://www.lifetechnologies.com/oligoperfect)) and are given below. The fragment obtained was introduced into the pDONR221 (Invitrogen, CA, USA). Coding *VAMP711* sequence from the entry vector was subsequently introduced in the gateway compatible destination vector pMDC7_B(pUBQ) using the Invitrogen LR clonase(+) and the resulting construct was transformed into *Col-0* plants by floral dipping in *Agrobacterium tumefaciens* liquid culture. The T1 generation obtained was selected on hygromycin B supplemented MS plates.

Chemicals {#s4-2}
---------

All chemicals were dissolved in DMSO and were applied in solid ½ MS-medium. Only dyes were applied in liquid ½ MS-medium before imaging. 1-naphthaleneacetic acid (NAA) was obtained from Duchefa (Netherlands), 5-F-IAA, estradiol, FM4-64, L-kynurenine (Kyn) and propidium iodide (PI) from Sigma (MO, USA), wortmannin (WM) from Cayman Chemical (MI, USA), MDY-64 from life technologies (CA, USA) and auxinole was kindly provided by Ken-ichiro Hayashi ([@bib12]).

Phenotype analysis {#s4-3}
------------------

For analysing the vacuolar morphology and cell length change, all the experiments were carried out on 7 days old seedlings. For analysing the vacuolar morphology index, optical confocal sections (above the cell nucleus) of the root epidermis were acquired and processed in imageJ. Images were taken in the late meristematic zone (position shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The largest luminal structure in five tricho- and/or atrichoblast cells were quantified by measuring the longest to widest distance and processed by multiplying the values. Means and standard error were calculated and statistical significance was evaluated by the Student\'s *t*-test using graphpad (<http://www.graphpad.com/quickcalcs/>). Figures display a representative experiment (out of three independent repetitions) utilising eight individual roots. The cell length change in the late meristematic zone (position shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) was quantified in the median epidermal confocal section decorated with propidium iodide to visualise the cell wall. Cell length measurements in the late meristematic zone were performed in imageJ by quantifying the length of four tricho- and/or atrichoblast cells which were averaged. Means and standard error were calculated and statistical significance was evaluated by the Student\'s *t*-test using graphpad (<http://www.graphpad.com/quickcalcs/>). Figures show a representative experiment (out of three independent repetitions) utilising 10 individual roots. To estimate the position for the cell length measurements in the elongation zone, seedlings were stained in propidium iodide for 5 min and subsequently imaged choosing the position were no propidium iodide (0.02 mg/ml) entered the vasculature, showing fully developed endodermal diffusion barriers. Length measurements of epidermal root hair cells were performed in imageJ by quantifying the length of individual cells which were averaged. Means and standard error were calculated and statistical significance was evaluated by the Student\'s *t*-test using graphpad (<http://www.graphpad.com/quickcalcs/>). Figures show a representative experiment (out of three independent repetitions) utilising 10 individual roots. In each root approximately three cells were quantified. For analysis of the root length, seedlings grown in vertically orientated plates were scanned on a flat-bed scanner and measurements were performed in imageJ. Per condition, 20--25 seedlings were analysed (for each experiment) 8 days after germination. Means and standard error were calculated and statistical significance was evaluated by the Student\'s *t*-test using graphpad (<http://www.graphpad.com/quickcalcs/>). Figures show a representative experiment (out of three independent repetitions).

Protein immunoblot analysis {#s4-4}
---------------------------

Root samples (∼50 mg each) of 7 days old *pUBQ10::VAMP711-YFP* expressing seedlings were shock-frozen and homogenised in liquid nitrogen, then 150 µl extraction buffers (67 mM TRIS pH 6.8, 133 mM DTT, 2.7% SDS, 13% glycerol, 0.01% bromophenol blue) were added and immediately incubated at 95°C for 5 min. After centrifugation, 15 µl of the extracts were separated by SDS-PAGE (10% gel) and blotted onto a 0.2 µm polyvinylidene difluoride membrane (BioRad). After blocking with a solution of 5% skim milk powder in TBS-T (150 mM NaCl, 10 mM TRIS/HCl pH = 8.0, 0.1% Tween 20) the membrane was probed with an anti-GFP antibody (JL-8; Clontech; Takara Bio Europe, Japan) diluted 1:2000 in skim milk TBS-T solution or anti-alpha-tubulin (B-5-1-1; Sigma) diluted 1:50000 in skim milk TBS-T solution. Horseradish peroxidase-conjugated goat anti-mouse antibody (Dianova, Germany) was employed as secondary antibody (1:20000). For detection, the SuperSignal West Pico chemiluminescent detection reagent (Thermo scientific, MA, USA) was used. Three independent root samples were quantified with imageJ and normalized to alpha-tubulin, means and standard error were calculated and statistical significance was evaluated by the Student\'s *t*-test using graphpad (<http://www.graphpad.com/quickcalcs/>). Figure shows a representative experiment (out of three independent repetitions).

Microscopy {#s4-5}
----------

For live cell imaging, wherever possible, roots were mounted in a propidium iodide (PI) solution (0.02 mg/ml) for counterstaining the cell walls. MDY-64 and FM4-64 staining was performed as described ([@bib32]). For 3D imaging, epidermal cells were recorded with a step size of 1 µm with approximately 17--20 single images. For image acquisition a Leica DM6000 CS, TCS AOBS confocal laser scanning microscope was used, equipped with a HCX PL APO CS 20.0 0.70 IMM UV or a HCX PL APO CS 63.0 × 1.20 WATER objective. Fluorescence signals of GFP (excitation 488 nm and emission 500 nm--546 nm), YFP (excitation 514 nm and emission 525 nm--578 nm), RFP (excitation 561 nm and emission 574 nm--618 nm), propidium iodide (excitation 561 nm and emission 577 nm--746 nm) and MDY-64 (excitation 458 nm and emission 465 nm--550 nm) were processed with the Leica software LAS AF 3.1 or with ImageJ (<http://rsb.info.nih.gov/ij/>) and data was statistically evaluated by Student\'s *t*-test using graphpad (<http://www.graphpad.com/quickcalcs/>). Representative images are shown.

Primer list and destination vector {#s4-6}
----------------------------------

VAMP711_ATTB1_fwd, GGGGACAAGTTTGTACAAAAAAGCAGGCTCGATGGCGATTCTGTACGCC, rev, GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAAATGCAAGATGGTAGAGTAGGTC; UBQ5 fwd, GACGCTTCATCTCGTCC, rev, GTAAACGTAGGTGAGTCCA.

Destination vector: pMDC7_B(pUBQ) ([@bib1]).
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Thank you for sending your work entitled "Auxin regulates SNARE-dependent vacuolar morphology restricting cell size" for consideration at *eLife*. Your article has been evaluated by Detlef Weigel (Senior editor) and 3 reviewers, as well as a member of our Board of Reviewing Editors.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

As you can see from their comments, the reviewers have substantive concerns regarding your work, and we would like to ask you to address them comprehensively. Especially:

1\) Please pay particular attention to the issues raised by reviewer 1, regarding the quantification of your markers. This issue is at the very heart of your manuscript, and we consider that it must be resolved to render your work publishable. Western blots for the other fusion proteins might be one way to provide more evidence, along with the reviewer\'s suggestions.

2\) Please also clarify the involvement of TIR1-type auxin signaling, which suggests that there must be a transcriptional effect in this regulation somewhere. If it is not directly targeting the SNARE expression, but something regulating it, then do the time scales allow the conclusion that the auxin regulation is nevertheless direct and not a secondary effect?

3\) The mutants that you present appear to have largely been published, nevertheless we would like to see evidence that the effects you report are due to those mutations, i.e. that you do not observe them in transgenically complemented plants.

*Reviewer \#1*:

The authors describe an interesting series of experiments suggesting that auxin increases the abundance of the vacuolar SNARE protein VTI11 and leads to a contraction of the vacuole resulting in a complex multi-lobed structure. These two observations are linked by the fact that a non-functional mutant allele *vti11* does not support the formation of the compact multi-lobed structures. Overall, this paper could make an interesting contribution to *eLife*.

Critical points to be fixed:

The increase in VTI11 abundance in the analyzed cell types is not convincing. The authors show a strong increase in the signal of a YFP fusion protein upon NAA treatment and conclude that this means increased protein levels. This conclusion is challenged by the fact that artificial overexpression of VAMP711 did not influence vacuolar morphology and, more importantly, that the lipid marker MDY64 shows exactly the same NAA-induced increase in fluorescence as the VAMP11-YFP ([Figures. 1E, F](#fig1){ref-type="fig"}). This draws the validity of the microscopic assessment of SNARE abundance into question, particularly because the authors showed similar NAA-dependent increases in the abundance for a number of other vacuolar SNAREs, and even for *syp21*, which is actually on a pre-vacuolar compartment. My concern is that the contraction of the vacuoles into compact structures might lead to erroneous measures of the fusion proteins, due to the fact that the authors evaluated only a single confocal section, probably through the center plane of these cells, rather than a stack of images covering the entire depth. A consequence could be that in cells with voluminous vacuoles much of the vacuolar membranes lies outside the confocal section and will not be measured. In the contracted state, a greater share of this membrane should be closer to the center of the cell, leading to an increase in the fluorescence in the single confocal section.

The authors could rule out that their results are artefacts by addressing several points:

1\) Integrate the fluorescence signals of the various SNARE proteins through a stack of sections covering the entire cell.

2\) Do the same analysis for the lipid marker MDY64 and discuss the strong effect observed.

3\) Present negative controls that do not show an NAA-induced increase of fluorescence. YFP-fusions of other vacuolar membrane proteins should be analyzed.

4\) Re-decorate the blot in [Figure 3M](#fig3){ref-type="fig"} for several other vacuolar marker proteins in order to demonstrate specificity of the effect of VAMP11-YFP

*Minor comments*:

Many experiments use a YFP-fusion of VAMP11 and the fluorescence emission of YFP is very sensitive to pH changes. The authors should at least provide good arguments indicating that NAA does not change the intracellular pH to which the YFP tag is exposed.

Are the fluorescent protein tags on the cytosolic or on the lumenal side of the membrane?

It is not self-evident how an increase in vacuolar SNAREs could lead to a collapse to the vacuoles into a very compact morphology. The Discussion would be more stimulating if it presented at least some speculations on this issue.

The vacuolar morphology index appears too simplified in order to represent the complex morphological changes in a meaningful way. It arbitrarily selects only the largest vacuole in the picture as a measure, leaving aside the many small and medium-sized structures. Given this, the statistical analysis of such results appears as formally correct but of questionable relevance. I would have preferred to see an analysis of the total vacuolar volume in these cells, which may be the parameter that is most relevant for cell expansion.

*Reviewer \#2*:

Löfke et al. use *Arabidopsis* root epidermis to show how auxin controls growth of growth-competent cells via stabilising protein components of the SNARE complex, which in turn regulate vacuole morphology. A range of genetic and chemical approaches has been taken and the results generally support the conclusions made by the authors. The manuscript is well written and the unravelling of this auxin-dependent control of vacuole morphology and cell growth will be interesting to a wide audience of cell and developmental biologists not restricted to the plant field. Below are some points for the authors to address, not in any particular order.

In the subsection headed "Vacuolar SNARE function is required for the auxin-dependent modulation of vacuolar morphology", paragraphs 1 and 2 could be made clearer. In the reference to the redundant action of SNARE components, the *vti11* mutant is mentioned as displaying roundish vacuoles. Does this mean that *vti11* is the only mutant in a SNARE-encoding gene that has a phenotype? Also it would be useful to explain earlier what it means that VTI11 is a Qb-SNARE (see point on SNARE background below). Finally, since the vacuole morphology is clearly different in the *vti11* mutant from that in wild type, it is puzzling why the authors indicate that the defects in SNARE-dependent vacuolar morphology regulation in *vti11* are relatively mild. Perhaps they mean that the altered vacuolar morphology in *vti11* has little effect on cell growth in A and T cells?

The authors explain in the discussion that lack of increased growth by WM treatment ([Figure 6--figure supplement 1](#fig6s1){ref-type="fig"}) and in the atrichoblasts of the *vti11* mutant (Figure 5--figure supplement 2) could be due to cell wall limitations. I think they can expand their reasoning to include that the increased growth observed upon Kynurenin treatment in [Figure 1](#fig1){ref-type="fig"} suggests that auxin acts not only on SNAREs/vacuolar morphology, but may also restrict growth by inhibiting availability of cell wall components.

Along the same line, it seems to me a discussion could be included on coordination between tricholast and atrichoblast cell files as well as cell divisions within a cell file. For example, do any of the genetic and pharmological treatments lead to a difference in the ratio of trichoblasts:atrichoblasts in the meristematic zone or total number of cells?

[Figure 6 and 7](#fig6 fig7){ref-type="fig"} could be amalgamated into one figure. [Figure 7A-D](#fig7){ref-type="fig"} panels are identical to [Figure 6A-D](#fig6){ref-type="fig"} panels except for the higher amount of NAA. Same goes for [Figure 7F-I](#fig7){ref-type="fig"} and [Figure 6G-J](#fig6){ref-type="fig"}. I suggest adding [Figure 7E and 7J](#fig7){ref-type="fig"} to [Figure 6](#fig6){ref-type="fig"} and turn [Figure 7A-D, F-I](#fig7){ref-type="fig"} into [Figure 6--figure supplement 2](#fig6s2){ref-type="fig"}.

In the subsection headed "Auxin effect on vacuolar morphogenesis interrelates with auxin-dependent cellular growth inhibition" a paragraph describes the effect of VTI11 and PI4K activity on root epidermal cell length (elongation zone) and overall root growth. Two points: 1) It is mentioned in the legend to [Figure 8](#fig8){ref-type="fig"} that trichoblasts were measured. Why not atrichoblasts? 2) It is surprising that WM treatment alone has a negative effect on growth ([Figure 8I](#fig8){ref-type="fig"}). If anything, it would be expected to be positive. Can the authors explain this?

*Minor comments*:

Some of the headings could be made more specific. For example, "Interference with the auxin effect on vacuolar SNAREs impedes auxin-dependent cell size control", this heading should refer to the connection made with PI-dependent processes.

I appreciate that space is limiting, but the minimal background information on the SNARE complex makes it difficult to relate to their role in this process. A few additional sentences to introduce SNARE would be useful. For example: 1) one gets the impression that SNAREs only exist in yeast and plants, although they indeed are common to all multicellular eukaryotic organisms, 2) mention their function in controlling membrane fusion, and 3) it would be useful to let the reader know what they are composed of such that the reader is prepared for what the Qb-SNARE VTI11 is.

*Reviewer \#3*:

This paper reports on the dramatic effect auxin can have on the shape of root tip cell vacuoles. The data indicate that via auxin receptors, auxin can regulate the abundance of vacuolar SNARES in particular the QbSNARE VTI11. The authors have quantified the effect by designing a vacuolar morphology index, so that they can compare vacuolar morphology in the various mutants and treated root tips. The method of quantification is relatively simple and crude but does effectively reflect the changes in vacuolar morphology which in some cases are visually very striking. I\'m sure with time the group will develop better methods of assaying the changed in vacuolar morphology.

In general the study is well presented and the paper well written and is a substantial contribution to the field. I feel that the authors have been a little cautious in their Discussion and have made little attempt to hypothesis as to why a vacuolar SNARE may have such a dramatic effect on vacuolar morphology. It is difficult to tell if in some of the micrographs we are looking at many individual vacuoles which have not fused together due to lack of SNARE complexes or whether they are all interconnected but just change in morphology. A bit of speculation would be good.

*Minor comments*:

In the beginning of the subsection headed "Vacuolar SNARE function is required for the auxin-dependent modulation of vacuolar morphology", perhaps you need to introduce VTI11 here or at least put it in the section heading.

In the Discussion section, I really wonder whether turgor exerted by the vacuole in the root tip is important. The vacuole appears very pleomorphic at this stage of development.

10.7554/eLife.05868.024

Author response

*1) Please pay particular attention to the issues raised by reviewer 1, regarding the quantification of your markers. This issue is at the very heart of your manuscript, and we consider that it must be resolved to render your work publishable. Western blots for the other fusion proteins might be one way to provide more evidence, along with the reviewer\'s suggestions*.

We thank particularly reviewer 1 for raising these concerns. We accordingly paid particular attention to the quantification of vacuolar SNAREs and performed several experiments. 1) We experimentally excluded that membrane crowding accounts for the observed increase in fluorescent intensity. 2) Moreover, we performed detailed z-stack imaging, confirming our previous single section results on auxin induced increase in cellular abundance of vacuolar SNAREs. 3) In agreement, we also performed additional western blots, confirming that auxin increases the abundance of several vacuolar SNARE proteins. 4) Finally, we included an additional vacuolar marker NET4a-GFP in all our experiments, which fluorescent intensity or protein abundance is not affected by auxin. This set of experiments illustrates that auxin affects SNARE abundance at the tonoplast. The additional data is shown in [Figure 4](#fig4){ref-type="fig"} and [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}.

*2) Please also clarify the involvement of TIR1-type auxin signaling, which suggests that there must be a transcriptional effect in this regulation somewhere*. *If it is not directly targeting the SNARE expression, but something regulating it, then do the time scales allow the conclusion that the auxin regulation is nevertheless direct and not a secondary effect?*

We once again thank you for the very valuable suggestion. We focused on the time scale of the auxin effect on vacuolar morphology as suggested. Accordingly, we emphasized on detailed time course experiments. First of all we reveal that the auxin effect on vacuolar morphology increases in time. Moreover, we could detect the first auxin induced morphological change of the vacuole within 15-30 minutes. This time frame is within in the time scale of fast genomic responses. Moreover, this finding also allowed us to illustrate that the auxin effect on vacuolar morphology preceded the auxin impact on cell size, which required ∼ 45 minutes. We included the data in the revised manuscript ([Figure 2](#fig2){ref-type="fig"}).

*3) The mutants that you present appear to have largely been published, nevertheless we would like to see evidence that the effects you report are due to those mutations, i.e. that you do not observe them in transgenically complemented plants*.

The interpretation of the *vti11* mutant phenotype is indeed central in our manuscript and, hence, we followed the suggestion, utilizing a functional pVTI11::VTI11-GFP construct to complement the *vti11* mutant phenotypes. Notably, VTI11-GFP expression in *vti11* mutant epidermal cells did not only rescue vacuolar morphology in untreated conditions, but also reversed auxin sensitivity in regards to vacuolar morphology and organ root growth. The new set of data and its quantification is now shown in [Figure 6--figure supplement 3](#fig6s3){ref-type="fig"}.

Reviewer \#1:

*1) Integrate the fluorescence signals of the various SNARE proteins through a stack of sections covering the entire cell*.

We followed the reviewer's suggestion and imaged again all used SNARE markers and integrated the signals through a stack of sections covering the entire cell. The new data confirms our previous single section data and is now shown in [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}. To further guide the reader on the exact optical sectioning in our figures (position for quantifications of 2D images), we also included a 3D overview screen of the root and VAMP711-YFP distribution in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}.

*2) Do the same analysis for the lipid marker MDY64 and discuss the strong effect observed*.

We followed the reviewer's suggestion and performed simultaneously image acquisition of VAMP711-Y/RFP and lipid markers MDY-64 and FM4-64. We did not detect any signal increase of MDY-64 or FM4-64 as compared to VAMP711-Y/RFP. The previous pictures must have been misleading and we apologize for not choosing representative pictures in the previous version. The new data is now shown in [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}.

*3) Present negative controls that do not show an NAA-induced increase of fluorescence. YFP-fusions of other vacuolar membrane proteins should be analyzed*.

We appreciate the suggestion and included the tonoplast marker NET4A-GFP, which was not affected by auxin. This suggests certain specificity for the auxin effect on vacuolar SNAREs. The new data is now shown in [Figure 4G, H](#fig4){ref-type="fig"}.

*4) Re-decorate the blot in* [*Figure 3M*](#fig3){ref-type="fig"} *for several other vacuolar marker proteins in order to demonstrate specificity of the effect of VAMP11-YFP*

We followed the reviewer's suggestion and have performed western blot analysis including additional SNARE proteins and the NET4A-GFP (as a negative control). The data is now included in [Figure 4](#fig4){ref-type="fig"}.

Minor comments:

*Many experiments use a YFP-fusion of VAMP11 and the fluorescence emission of YFP is very sensitive to pH changes. The authors should at least provide good arguments indicating that NAA does not change the intracellular pH to which the YFP tag is exposed*.

We are grateful for this comment and assume many readers will have similar concerns. Therefore, we included a discussion on this aspect in the revised version of the manuscript. In our experiments we used VAMP711 fusion proteins to RFP and YFP. RFP and YFP proteins have very distinct sensitivities to pH changes, but both fusion proteins showed comparable auxin induced increase in fluorescent intensity. Moreover, previous work ([@bib11]) suggested that exogenous application of auxin does not detectably affect cytosolic pH. Hence, we conclude that the observed effects are not likely related to changes in cytosolic pH.

*Are the fluorescent protein tags on the cytosolic or on the lumenal side of the membrane*?

The fluorescent tags are facing the cytosol. This information is now included in the revised version of the manuscript.

*It is not self-evident how an increase in vacuolar SNAREs could lead to a collapse to the vacuoles into a very compact morphology. The Discussion would be more stimulating if it presented at least some speculations on this issue*.

This is indeed a very interesting question. We assume that auxin could trigger a conformational change of SNAREs, which may affect its activity. Alternatively, vacuolar SNAREs could also provide a structural component required for vacuolar organisation. We currently investigate these options. At the current stage we can only speculate and we followed the reviewer's suggestion and elaborated on our Discussion.

*The vacuolar morphology index appears too simplified in order to represent the complex morphological changes in a meaningful way. It arbitrarily selects only the largest vacuole in the picture as a measure, leaving aside the many small and medium-sized structures. Given this, the statistical analysis of such results appears as formally correct but of questionable relevance. I would have preferred to see an analysis of the total vacuolar volume in these cells, which may be the parameter that is most relevant for cell expansion*.

The vacuole is a highly complex structure, which is visually distinct in every cell. Long term auxin treatments and its effect on vacuolar shapes are very easily detectable by eye. However, shorter time points require a solid quantification method to capture morphological changes. We implemented the vacuolar morphology index to detect such major changes in vacuolar morphology. Notably, the measurement of the biggest vacuolar structure turned out to be a very reproducible approximation for vacuolar morphology. Importantly the measured values are quite stable in between independent experiments (both untreated and treated). Moreover, the index is quite sensitive to auxin induced morphological changes, which guided us to depict earliest morphological changes following short-term auxin treatments. Notably, the vacuolar morphology index robustly correlates with the auxin effect on cell sizes. Therefore, we feel that this simple quantification method is straightforward and very suitable for the here conducted work. In this respect, we kindly agree also with reviewer 3 ("The method of quantification is relatively simple and crude but does effectively reflect the changes in vacuolar morphology which in some cases are visually very striking."). Said that we also would like to mention that we would indeed further develop tools to depict and quantify the plant vacuoles. In our on-going research, we are also investigating the potential effect of auxin on vacuolar volume and whether it is a parameter that is most relevant. We will develop in the future more sophisticated 3D imaging approaches, which will allow us to address additional questions, such as raised by reviewer 1.

Reviewer \#2:

*In the subsection headed "Vacuolar SNARE function is required for the auxin-dependent modulation of vacuolar morphology",paragraphs 1 and 2 could be made clearer. In the reference to the redundant action of SNARE components, the* vti11 *mutant is mentioned as displaying roundish vacuoles. Does this mean that* vti11 *is the only mutant in a SNARE-encoding gene that has a phenotype? Also it would be useful to explain earlier what it means that VTI11 is a Qb-SNARE (see point on SNARE background below).*

We thank the reviewer for pointing out the lack of discussion and improved the Introduction and Discussion on SNARE proteins. It has been previously shown that several SNARE complex components indeed function redundantly. Some mutants display defects in storage vacuoles and mild growth phenotypes (e.g. Shirakawa et al., 2010). However, based on our analysis most mutants did not show any defects in vacuolar morphology.

*Finally, since the vacuole morphology is clearly different in the* vti11 *mutant from that in wild type, it is puzzling why the authors indicate that the defects in SNARE-dependent vacuolar morphology regulation in* vti11 *are relatively mild. Perhaps they mean that the altered vacuolar morphology in* vti11 *has little effect on cell growth in A and T cells?*

This formulation was indeed confusing. We intended to point out that in the *vti11* mutant vacuolar morphology is still differentially regulated in tricho- and atrichoblast. In the revised version of the manuscript, we reformulated the sentence: "Despite these apparent defects, vacuoles remained differentially controlled in *vti11* mutant tricho- and atrichoblast cells, indicating that the cell type-dependent regulation of vacuolar morphology is at least partially operational in *vti11* mutants."

*The authors explain in the discussion that lack of increased growth by WM treatment (*[*Figure 6--figure supplement 1*](#fig6s1){ref-type="fig"}*) and in the atrichoblasts of the* vti11 *mutant (Figure 5--figure supplement 2) could be due to cell wall limitations. I think they can expand their reasoning to include that the increased growth observed upon Kynurenin treatment in* [*Figure 1*](#fig1){ref-type="fig"} *suggests that auxin acts not only on SNAREs/vacuolar morphology, but may also restrict growth by inhibiting availability of cell wall components.*

Yes, we agree with the reviewer, this data is in agreement with a dual role of auxin. Upcoming research in our group will further decipher this interplay.

*Along the same line, it seems to me a discussion could be included on coordination between tricholast and atrichoblast cell files as well as cell divisions within a cell file. For example, do any of the genetic and pharmological treatments lead to a difference in the ratio of trichoblasts:atrichoblasts in the meristematic zone or total number of cells*?

Indeed pharmacological treatments (high and low auxin conditions) lead to a change in the ratio of tricho- and atrichoblasts ([Author response image 1](#fig9){ref-type="fig"}). We currently assume that plant tissues do not show cellular sliding due to the cell wall. Hence, cell division could contribute to the observed differences (especially after prolonged auxin treatments). This was also the reasoning to include analysis that assesses auxin-dependent growth repression in the elongation zone. We improved the underlying discussion in the revised version of the manuscript. In fact, we are currently testing whether we could use light sheet-based microscopy to follow prolonged auxin treatments in time. This approach would allow us to perform the required life cell imaging and to reveal or exclude the vacuolar requirements for cellular division.10.7554/eLife.05868.025Author response image 1.**DOI:** [http://dx.doi.org/10.7554/eLife.05868.025](10.7554/eLife.05868.025)

[*Figure 6 and 7*](#fig6 fig7){ref-type="fig"} *could be amalgamated into one figure.* [*Figure 7A-D*](#fig7){ref-type="fig"} *panels are identical to* [*Figure 6A-D*](#fig6){ref-type="fig"} *panels except for the higher amount of NAA. Same goes for* [*Figure 7F-I*](#fig7){ref-type="fig"} *and* [*Figure 6G-J*](#fig6){ref-type="fig"}*. I suggest adding* [*Figure 7E and 7J*](#fig7){ref-type="fig"} *to* [*Figure 6*](#fig6){ref-type="fig"} *and turn* [*Figure 7A-D, F-I*](#fig7){ref-type="fig"} *into* [*Figure 6--figure supplement 2*](#fig6s2){ref-type="fig"}.

We followed the advice and amalgamated [Figure 6 and 7](#fig6 fig7){ref-type="fig"} into one figure and created a new figure supplement ([Figure 6--figure supplement 3](#fig6s3){ref-type="fig"}).

*In the subsection headed "Auxin effect on vacuolar morphogenesis interrelates with auxin-dependent cellular growth inhibition" a paragraph describes the effect of VTI11 and PI4K activity on root epidermal cell length (elongation zone) and overall root growth. Two points: 1) It is mentioned in the legend to* [*Figure 8*](#fig8){ref-type="fig"} *that trichoblasts were measured. Why not atrichoblasts*?

These were rather technical reasons. Visual limitations of single sections imposed the practical depiction of trichoblast cells. We used medium sections to depict the start of the differentiation zone (functional endodermal diffusion barrier). In these sections, a cell "without" hairs could be still a trichoblast cell whose root hair was simply not in focus. Therefore, we considered for our measurments only cells showing a root hair, which ensured that we measured only one cell type. We assume that relative tissue expansion is constant between tricho- and atrichoblasts. Therefore, the relative outcome would be the same if we had used atrichoblasts.

*And 2) It is surprising that WM treatment alone has a negative effect on growth (*[*Figure 8I*](#fig8){ref-type="fig"}*). If anything, it would be expected to be positive. Can the authors explain this*?

Besides its effect on vacuolar morphology, WM interferes with several intracellular processes and it is likely to interfere with growth. It indeed has been previously shown that high levels of WM (33µM) have a negative impact on growth (Jaillais et al., 2006). We used very low WM concentrations and observed only a mild effect on growth. Besides its mild effect on growth, this concentration range did not only reveal auxin resistant vacuoles, but also reduced the auxin effect on cell size and root organ growth.

Minor comments:

*Some of the headings could be made more specific. For example, "Interference with the auxin effect on vacuolar SNAREs impedes auxin-dependent cell size control", this heading should refer to the connection made with PI-dependent processes*.

We thank the reviewer for this suggestion and revised the heading accordingly: "Interference with phosphatidylinositol homeostasis affects vacuolar SNAREs and impedes auxin-dependent cell size control."

*I appreciate that space is limiting, but the minimal background information on the SNARE complex makes it difficult to relate to their role in this process. A few additional sentences to introduce SNARE would be useful. For example: 1) one gets the impression that SNAREs only exist in yeast and plants, although they indeed are common to all multicellular eukaryotic organisms, 2) mention their function in controlling membrane fusion, and 3) it would be useful to let the reader know what they are composed of such that the reader is prepared for what the Qb-SNARE VTI11 is*.

We appreciate the very valuable suggestion and included more detailed background information on the SNAREs in the revised version of the manuscript.

Reviewer \#3:

*I feel that the authors have been a little cautious in their Discussion and have made little attempt to hypothesis as to why a vacuolar SNARE may have such a dramatic effect on vacuolar morphology*.

We thank the reviewer for this suggestion. We indeed were very cautious in the previous version, because we did not directly address these questions. However, we agree with the reviewer and substantiated the discussion on vacuolar SNAREs in the revised version of the manuscript.

*It is difficult to tell if in some of the micrographs we are looking at many individual vacuoles which have not fused together due to lack of SNARE complexes or whether they are all interconnected but just change in morphology. A bit of speculation would be good*.

We again thank the reviewer to address this very interesting question. We included a paragraph discussing the possibility of interconnected vacuoles and cited also the latest results by Viotti et al., 2013. Ongoing research in our group is actually addressing this eminent question.

Minor comments:

*In the beginning of the subsection headed "Vacuolar SNARE function is required for the auxin-dependent modulation of vacuolar morphology", perhaps you need to introduce VTI11 here or at least put it in the section heading*.

We followed the reviewer's suggestion and included VTI11 in the section heading.

*In the Discussion section, I really wonder whether turgor exerted by the vacuole in the root tip is important. The vacuole appears very pleomorphic at this stage of development*.

We agree with the reviewer and discussed this issue accordingly: "Hence, the potential role of auxin in turgor regulation should also be carefully assessed. Just such a role has been insinuated in recent papers related to lateral root emergence. Auxin responses have been reported to reduce cellular pressure in cell files facing lateral root primordia ([@bib24]) and vacuolar morphology alterations have been recently described in endodermal tissues during lateral root emergence ([@bib35], [@bib24]). However, these proposed auxin responses are not related to cellular growth regulation and it remains to be seen whether the auxin impact on vacuolar morphology described here is related to interference with turgor pressure."
